Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Parkinson Disease | 57 | 2024 | 2859 | 5.100 |
Why?
|
DNA, Mitochondrial | 26 | 2019 | 858 | 3.720 |
Why?
|
Arthritis, Psoriatic | 6 | 2024 | 219 | 1.420 |
Why?
|
Creatine | 6 | 2017 | 426 | 1.260 |
Why?
|
DNA-Directed DNA Polymerase | 4 | 2015 | 491 | 1.130 |
Why?
|
Caffeine | 3 | 2017 | 702 | 0.990 |
Why?
|
MPTP Poisoning | 2 | 2014 | 37 | 0.910 |
Why?
|
Psoriasis | 5 | 2024 | 940 | 0.880 |
Why?
|
Thiolester Hydrolases | 1 | 2023 | 85 | 0.860 |
Why?
|
Neuroprotective Agents | 4 | 2021 | 961 | 0.820 |
Why?
|
Oxidative Phosphorylation | 3 | 2013 | 495 | 0.750 |
Why?
|
Mitochondria | 10 | 2023 | 3600 | 0.750 |
Why?
|
Duodenum | 1 | 2023 | 486 | 0.700 |
Why?
|
Parkinsonian Disorders | 3 | 2016 | 284 | 0.680 |
Why?
|
Eosinophilia | 1 | 2023 | 559 | 0.630 |
Why?
|
Glycolysis | 2 | 2013 | 828 | 0.630 |
Why?
|
Point Mutation | 7 | 2010 | 1594 | 0.630 |
Why?
|
Olfaction Disorders | 1 | 2021 | 224 | 0.610 |
Why?
|
Disease Progression | 12 | 2021 | 13502 | 0.600 |
Why?
|
Mutation | 17 | 2019 | 29932 | 0.590 |
Why?
|
Substantia Nigra | 7 | 2023 | 350 | 0.590 |
Why?
|
Antiparkinson Agents | 6 | 2024 | 183 | 0.580 |
Why?
|
Dopamine | 5 | 2024 | 1595 | 0.580 |
Why?
|
Dystonic Disorders | 6 | 2011 | 340 | 0.570 |
Why?
|
Nortropanes | 1 | 2016 | 12 | 0.560 |
Why?
|
alpha-Synuclein | 5 | 2023 | 749 | 0.560 |
Why?
|
Aging | 11 | 2015 | 8651 | 0.550 |
Why?
|
Dopamine Agents | 3 | 2017 | 189 | 0.540 |
Why?
|
Abdominal Pain | 1 | 2023 | 1063 | 0.540 |
Why?
|
Appendicitis | 1 | 2023 | 674 | 0.530 |
Why?
|
Patient Care Management | 1 | 2019 | 303 | 0.530 |
Why?
|
Lewy Body Disease | 2 | 2012 | 252 | 0.520 |
Why?
|
Superior Colliculi | 6 | 1992 | 98 | 0.510 |
Why?
|
Intracranial Hypotension | 1 | 2015 | 40 | 0.500 |
Why?
|
Deoxyguanosine | 1 | 2015 | 92 | 0.480 |
Why?
|
Genetic Predisposition to Disease | 14 | 2024 | 17790 | 0.470 |
Why?
|
Movement Disorders | 2 | 2016 | 459 | 0.470 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 2 | 2017 | 893 | 0.460 |
Why?
|
Neuroacanthocytosis | 2 | 2023 | 6 | 0.450 |
Why?
|
Transcription Factors | 7 | 2020 | 12103 | 0.440 |
Why?
|
Sodium Chloride | 1 | 2015 | 591 | 0.440 |
Why?
|
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2012 | 90 | 0.420 |
Why?
|
Apoptosis Regulatory Proteins | 7 | 2011 | 1135 | 0.420 |
Why?
|
Dystonia | 3 | 2008 | 364 | 0.420 |
Why?
|
Thiazolidinediones | 1 | 2015 | 465 | 0.390 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2016 | 1067 | 0.380 |
Why?
|
Neurotransmitter Agents | 1 | 2015 | 663 | 0.380 |
Why?
|
Polymorphism, Genetic | 6 | 2012 | 4291 | 0.380 |
Why?
|
Brain | 15 | 2023 | 26951 | 0.370 |
Why?
|
Axons | 8 | 1994 | 1673 | 0.370 |
Why?
|
Epistasis, Genetic | 1 | 2012 | 350 | 0.350 |
Why?
|
Antioxidants | 4 | 2015 | 1667 | 0.330 |
Why?
|
NADH Dehydrogenase | 3 | 2004 | 46 | 0.330 |
Why?
|
Acetylcysteine | 1 | 2010 | 264 | 0.320 |
Why?
|
Neostriatum | 1 | 2010 | 246 | 0.320 |
Why?
|
Vesicular Transport Proteins | 4 | 2023 | 374 | 0.320 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2012 | 599 | 0.320 |
Why?
|
Neurons | 8 | 2014 | 9426 | 0.320 |
Why?
|
Oxidative Stress | 9 | 2023 | 3106 | 0.300 |
Why?
|
Alzheimer Disease | 6 | 2019 | 8547 | 0.300 |
Why?
|
Age of Onset | 9 | 2017 | 3301 | 0.290 |
Why?
|
Retina | 7 | 1994 | 2635 | 0.290 |
Why?
|
Tyrosine 3-Monooxygenase | 3 | 2014 | 370 | 0.290 |
Why?
|
Heat-Shock Proteins | 1 | 2011 | 795 | 0.280 |
Why?
|
Humans | 114 | 2024 | 760621 | 0.280 |
Why?
|
Inheritance Patterns | 2 | 2010 | 340 | 0.280 |
Why?
|
Rheumatology | 2 | 2024 | 611 | 0.280 |
Why?
|
Electron Transport Complex I | 2 | 2007 | 152 | 0.280 |
Why?
|
Radiopharmaceuticals | 1 | 2016 | 2634 | 0.270 |
Why?
|
Mutation, Missense | 8 | 2010 | 2566 | 0.270 |
Why?
|
Sirolimus | 1 | 2013 | 1547 | 0.270 |
Why?
|
Spinocerebellar Ataxias | 1 | 2007 | 104 | 0.270 |
Why?
|
DNA-Binding Proteins | 9 | 2011 | 9585 | 0.260 |
Why?
|
Cadmium | 3 | 2012 | 215 | 0.260 |
Why?
|
Glucosylceramidase | 2 | 2024 | 125 | 0.260 |
Why?
|
Energy Metabolism | 2 | 2018 | 2869 | 0.260 |
Why?
|
Hemolytic-Uremic Syndrome | 1 | 2006 | 106 | 0.250 |
Why?
|
Levodopa | 2 | 2024 | 217 | 0.250 |
Why?
|
Aging, Premature | 2 | 2019 | 44 | 0.250 |
Why?
|
Genotype | 5 | 2017 | 12960 | 0.250 |
Why?
|
Trans-Activators | 2 | 2012 | 2860 | 0.250 |
Why?
|
Waiting Lists | 1 | 2009 | 763 | 0.240 |
Why?
|
Interleukin-6 | 1 | 2015 | 3215 | 0.240 |
Why?
|
Central Nervous System Stimulants | 2 | 2015 | 1174 | 0.240 |
Why?
|
Middle Aged | 51 | 2024 | 220352 | 0.230 |
Why?
|
Neuroglia | 2 | 2012 | 944 | 0.230 |
Why?
|
Cataplexy | 1 | 2004 | 61 | 0.230 |
Why?
|
Glomerulonephritis | 1 | 2006 | 337 | 0.230 |
Why?
|
Dyskinesia, Drug-Induced | 1 | 2024 | 165 | 0.230 |
Why?
|
Brain Chemistry | 1 | 2007 | 959 | 0.220 |
Why?
|
Frontal Bone | 1 | 2004 | 105 | 0.220 |
Why?
|
Metallurgy | 3 | 2013 | 95 | 0.220 |
Why?
|
Nuclear Proteins | 7 | 2011 | 5791 | 0.220 |
Why?
|
Male | 62 | 2024 | 359744 | 0.220 |
Why?
|
Homeodomain Proteins | 1 | 2012 | 2414 | 0.220 |
Why?
|
Dermatology | 2 | 2024 | 914 | 0.210 |
Why?
|
DNA Mutational Analysis | 9 | 2016 | 4107 | 0.210 |
Why?
|
Triage | 1 | 2009 | 987 | 0.210 |
Why?
|
Aged | 40 | 2024 | 169152 | 0.200 |
Why?
|
Hypoglycemic Agents | 1 | 2015 | 3150 | 0.200 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2024 | 15789 | 0.190 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2717 | 0.190 |
Why?
|
Female | 57 | 2024 | 391270 | 0.190 |
Why?
|
Inosine | 1 | 2021 | 130 | 0.180 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2001 | 93 | 0.180 |
Why?
|
Health Services, Indigenous | 1 | 2021 | 68 | 0.180 |
Why?
|
Lumbar Vertebrae | 1 | 2009 | 1868 | 0.170 |
Why?
|
Lead | 4 | 2013 | 880 | 0.170 |
Why?
|
Connective Tissue | 1 | 2021 | 416 | 0.170 |
Why?
|
Gene Frequency | 5 | 2012 | 3615 | 0.170 |
Why?
|
Creatinine | 4 | 2013 | 1903 | 0.170 |
Why?
|
Animals | 31 | 2023 | 167963 | 0.170 |
Why?
|
Diffuse Cerebral Sclerosis of Schilder | 1 | 1998 | 18 | 0.160 |
Why?
|
Ubiquitination | 1 | 2023 | 1008 | 0.160 |
Why?
|
Gait | 1 | 2004 | 812 | 0.160 |
Why?
|
Smell | 1 | 2021 | 259 | 0.160 |
Why?
|
Models, Biological | 2 | 2013 | 9467 | 0.160 |
Why?
|
Metabolism | 1 | 2019 | 193 | 0.150 |
Why?
|
Adult | 37 | 2021 | 219994 | 0.150 |
Why?
|
Muscle Weakness | 1 | 2021 | 413 | 0.150 |
Why?
|
Lysosomal Storage Diseases | 1 | 1998 | 79 | 0.150 |
Why?
|
Peroxidase | 1 | 2021 | 605 | 0.150 |
Why?
|
Glycolipids | 1 | 1998 | 204 | 0.150 |
Why?
|
Mice | 13 | 2023 | 81208 | 0.150 |
Why?
|
Diseases in Twins | 1 | 1999 | 447 | 0.150 |
Why?
|
RNA, Transfer | 1 | 2000 | 289 | 0.150 |
Why?
|
Neuroimmunomodulation | 1 | 2019 | 177 | 0.140 |
Why?
|
Germinal Center | 1 | 2020 | 379 | 0.140 |
Why?
|
Cell Death | 2 | 2013 | 1672 | 0.140 |
Why?
|
Group VI Phospholipases A2 | 1 | 2016 | 16 | 0.140 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1266 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2009 | 3598 | 0.140 |
Why?
|
Flavobacteriaceae | 1 | 2016 | 8 | 0.140 |
Why?
|
Cell Count | 2 | 2014 | 1835 | 0.130 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2019 | 542 | 0.130 |
Why?
|
Aged, 80 and over | 15 | 2020 | 58995 | 0.130 |
Why?
|
Constipation | 1 | 2021 | 561 | 0.130 |
Why?
|
Urbanization | 1 | 2016 | 100 | 0.130 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12626 | 0.130 |
Why?
|
United Nations | 1 | 2016 | 151 | 0.130 |
Why?
|
Treatment Failure | 3 | 2021 | 2648 | 0.130 |
Why?
|
Occupational Exposure | 4 | 2013 | 1809 | 0.130 |
Why?
|
Inflammation | 3 | 2023 | 10756 | 0.130 |
Why?
|
Antibody Formation | 1 | 2020 | 1400 | 0.130 |
Why?
|
Homozygote | 3 | 2013 | 1788 | 0.130 |
Why?
|
Uric Acid | 1 | 2021 | 806 | 0.120 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7593 | 0.120 |
Why?
|
Injections, Spinal | 1 | 2015 | 316 | 0.120 |
Why?
|
Muscle Proteins | 1 | 2020 | 1152 | 0.120 |
Why?
|
Cataract | 1 | 2001 | 827 | 0.120 |
Why?
|
Carbocyanines | 5 | 1992 | 175 | 0.120 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8056 | 0.120 |
Why?
|
Reactive Oxygen Species | 4 | 2012 | 2138 | 0.120 |
Why?
|
Infertility | 1 | 2021 | 655 | 0.120 |
Why?
|
Heterozygote | 4 | 2013 | 2798 | 0.120 |
Why?
|
Genetic Variation | 3 | 2019 | 6551 | 0.120 |
Why?
|
Apolipoproteins E | 2 | 2015 | 1436 | 0.120 |
Why?
|
Biometry | 1 | 2017 | 559 | 0.120 |
Why?
|
Conservation of Natural Resources | 1 | 2016 | 211 | 0.120 |
Why?
|
Case-Control Studies | 8 | 2021 | 22053 | 0.120 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1889 | 0.110 |
Why?
|
Carnitine | 1 | 2015 | 252 | 0.110 |
Why?
|
Glutamates | 1 | 2015 | 391 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2019 | 968 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2873 | 0.110 |
Why?
|
Cities | 1 | 2016 | 538 | 0.110 |
Why?
|
Nerve Degeneration | 1 | 2018 | 748 | 0.110 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2015 | 428 | 0.110 |
Why?
|
Uranium | 1 | 2013 | 23 | 0.110 |
Why?
|
Dihydro-beta-Erythroidine | 1 | 1992 | 4 | 0.110 |
Why?
|
Base Sequence | 9 | 2011 | 12446 | 0.110 |
Why?
|
Mice, Knockout | 4 | 2023 | 14372 | 0.110 |
Why?
|
Acetylcholine | 1 | 2015 | 629 | 0.110 |
Why?
|
Osteoarthritis | 1 | 2021 | 1055 | 0.110 |
Why?
|
Optic Atrophy, Hereditary, Leber | 1 | 2013 | 50 | 0.110 |
Why?
|
2-Amino-5-phosphonovalerate | 1 | 1992 | 58 | 0.110 |
Why?
|
Polymerase Chain Reaction | 5 | 2010 | 6068 | 0.110 |
Why?
|
Aspartic Acid | 1 | 2015 | 576 | 0.110 |
Why?
|
Policy Making | 1 | 2016 | 538 | 0.110 |
Why?
|
Dystonia Musculorum Deformans | 5 | 2010 | 158 | 0.110 |
Why?
|
Antimony | 1 | 2012 | 19 | 0.100 |
Why?
|
Thallium | 1 | 2012 | 100 | 0.100 |
Why?
|
Longitudinal Studies | 7 | 2019 | 14495 | 0.100 |
Why?
|
Ubiquinone | 1 | 2014 | 183 | 0.100 |
Why?
|
Dizocilpine Maleate | 1 | 1992 | 172 | 0.100 |
Why?
|
Membrane Transport Proteins | 1 | 2018 | 1035 | 0.100 |
Why?
|
Mice, Transgenic | 4 | 2014 | 9530 | 0.100 |
Why?
|
Double-Blind Method | 7 | 2022 | 12427 | 0.100 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2012 | 86 | 0.100 |
Why?
|
Germany | 3 | 2021 | 873 | 0.100 |
Why?
|
Cartilage, Articular | 1 | 2019 | 1091 | 0.100 |
Why?
|
Cohort Studies | 8 | 2021 | 41335 | 0.100 |
Why?
|
Glomerular Filtration Rate | 4 | 2013 | 2180 | 0.100 |
Why?
|
Brain Diseases | 1 | 2001 | 1540 | 0.100 |
Why?
|
Voice Training | 1 | 2012 | 44 | 0.100 |
Why?
|
Research Personnel | 1 | 2016 | 582 | 0.100 |
Why?
|
Mitochondrial Myopathies | 2 | 2004 | 49 | 0.100 |
Why?
|
Physical Conditioning, Animal | 1 | 2015 | 366 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2418 | 0.100 |
Why?
|
Inferior Colliculi | 1 | 1992 | 69 | 0.100 |
Why?
|
Codon | 5 | 2010 | 602 | 0.090 |
Why?
|
Biofilms | 1 | 2016 | 621 | 0.090 |
Why?
|
NAD | 1 | 2015 | 609 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 820 | 0.090 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 1126 | 0.090 |
Why?
|
Craniocerebral Trauma | 1 | 2015 | 491 | 0.090 |
Why?
|
Adenosine Triphosphate | 3 | 2013 | 1993 | 0.090 |
Why?
|
Speech Disorders | 1 | 2012 | 180 | 0.090 |
Why?
|
Metabolic Diseases | 1 | 2017 | 686 | 0.090 |
Why?
|
Drug Interactions | 1 | 2015 | 1428 | 0.090 |
Why?
|
Gait Disorders, Neurologic | 1 | 2013 | 238 | 0.090 |
Why?
|
Genes, Mitochondrial | 1 | 2010 | 62 | 0.090 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4407 | 0.090 |
Why?
|
Likelihood Functions | 1 | 2013 | 987 | 0.090 |
Why?
|
Family Health | 4 | 2016 | 1257 | 0.090 |
Why?
|
MELAS Syndrome | 1 | 2010 | 56 | 0.090 |
Why?
|
Inclusion Bodies | 2 | 2004 | 281 | 0.090 |
Why?
|
Cystatin C | 1 | 2011 | 270 | 0.090 |
Why?
|
Gene Expression | 2 | 2015 | 7588 | 0.090 |
Why?
|
Mood Disorders | 1 | 2016 | 1124 | 0.090 |
Why?
|
Optic Nerve | 2 | 1991 | 567 | 0.080 |
Why?
|
Retinal Ganglion Cells | 2 | 1992 | 806 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2010 | 256 | 0.080 |
Why?
|
Rhabdomyolysis | 1 | 2010 | 155 | 0.080 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2012 | 454 | 0.080 |
Why?
|
Accidental Falls | 1 | 2017 | 1056 | 0.080 |
Why?
|
Amino Acid Substitution | 5 | 2010 | 1737 | 0.080 |
Why?
|
Pyrimidines | 1 | 2021 | 3016 | 0.080 |
Why?
|
Bone Density | 1 | 2021 | 3534 | 0.080 |
Why?
|
Oxygen Consumption | 2 | 2013 | 1843 | 0.080 |
Why?
|
Risk Assessment | 4 | 2021 | 24123 | 0.080 |
Why?
|
Severity of Illness Index | 8 | 2021 | 15840 | 0.080 |
Why?
|
Voice Disorders | 1 | 2012 | 286 | 0.080 |
Why?
|
Corpus Striatum | 1 | 2014 | 1233 | 0.080 |
Why?
|
Neuronal Plasticity | 2 | 1994 | 1430 | 0.080 |
Why?
|
Psychotherapy, Group | 1 | 2012 | 410 | 0.080 |
Why?
|
Pedigree | 4 | 2010 | 4578 | 0.080 |
Why?
|
Immunoglobulin G | 1 | 2020 | 4541 | 0.080 |
Why?
|
Diagnosis, Differential | 4 | 2016 | 12965 | 0.080 |
Why?
|
Glutathione | 1 | 2010 | 582 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22023 | 0.070 |
Why?
|
Vision, Ocular | 1 | 1991 | 454 | 0.070 |
Why?
|
Cuba | 1 | 2007 | 48 | 0.070 |
Why?
|
Genetic Diseases, Inborn | 1 | 2012 | 601 | 0.070 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1913 | 0.070 |
Why?
|
Dependovirus | 1 | 2012 | 709 | 0.070 |
Why?
|
Muscle, Skeletal | 3 | 2019 | 4925 | 0.070 |
Why?
|
Cytosol | 1 | 2010 | 887 | 0.070 |
Why?
|
Ataxia | 1 | 2009 | 305 | 0.070 |
Why?
|
Minocycline | 1 | 2008 | 168 | 0.070 |
Why?
|
DNA Repeat Expansion | 1 | 2007 | 72 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3959 | 0.070 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 2 | 2 | 2004 | 42 | 0.070 |
Why?
|
Survival Analysis | 3 | 2016 | 10182 | 0.070 |
Why?
|
B-Lymphocytes | 1 | 2020 | 4742 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3388 | 0.070 |
Why?
|
Odds Ratio | 4 | 2015 | 9716 | 0.070 |
Why?
|
Molecular Chaperones | 2 | 2009 | 752 | 0.070 |
Why?
|
Risk Factors | 8 | 2019 | 74359 | 0.070 |
Why?
|
Hot Temperature | 1 | 2013 | 1435 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 820 | 0.070 |
Why?
|
Rats | 11 | 2005 | 23711 | 0.070 |
Why?
|
Neurologic Examination | 2 | 2000 | 916 | 0.070 |
Why?
|
Metabolomics | 1 | 2015 | 1628 | 0.070 |
Why?
|
Neurodegenerative Diseases | 3 | 2006 | 1084 | 0.070 |
Why?
|
Prefrontal Cortex | 1 | 2016 | 2212 | 0.060 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2007 | 247 | 0.060 |
Why?
|
Synaptic Transmission | 1 | 1992 | 1171 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2010 | 1493 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 340 | 0.060 |
Why?
|
Child | 9 | 2023 | 79806 | 0.060 |
Why?
|
Kidney | 2 | 2011 | 7064 | 0.060 |
Why?
|
Heart Rate | 1 | 2017 | 4179 | 0.060 |
Why?
|
DNA Damage | 1 | 2015 | 2442 | 0.060 |
Why?
|
Patient Readmission | 1 | 2019 | 3323 | 0.060 |
Why?
|
Visual Cortex | 1 | 2013 | 1089 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 2913 | 0.060 |
Why?
|
Cell Line | 2 | 2013 | 15620 | 0.060 |
Why?
|
Genes, Archaeal | 1 | 2004 | 8 | 0.060 |
Why?
|
Methanococcus | 1 | 2004 | 10 | 0.060 |
Why?
|
Exons | 2 | 2009 | 2388 | 0.060 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2007 | 330 | 0.060 |
Why?
|
Twin Studies as Topic | 1 | 2005 | 104 | 0.060 |
Why?
|
Postmortem Changes | 1 | 2004 | 119 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12531 | 0.060 |
Why?
|
Astrocytes | 1 | 2012 | 1338 | 0.060 |
Why?
|
Botulinum Toxins | 1 | 2006 | 188 | 0.060 |
Why?
|
Microdissection | 1 | 2004 | 151 | 0.060 |
Why?
|
Protein Transport | 1 | 2010 | 1964 | 0.060 |
Why?
|
Graft Survival | 2 | 2012 | 3794 | 0.060 |
Why?
|
Liver Transplantation | 2 | 2016 | 2325 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.060 |
Why?
|
Cytochromes b | 1 | 2004 | 34 | 0.060 |
Why?
|
Glycoproteins | 1 | 2012 | 2208 | 0.060 |
Why?
|
Occupational Diseases | 1 | 2012 | 1486 | 0.060 |
Why?
|
Hepatitis C, Chronic | 1 | 2012 | 1031 | 0.060 |
Why?
|
HLA-DQ Antigens | 1 | 2004 | 211 | 0.060 |
Why?
|
Cardiomyopathies | 2 | 2010 | 1952 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 1 | 2019 | 3763 | 0.060 |
Why?
|
Neoplasms | 1 | 2013 | 22072 | 0.060 |
Why?
|
Free Radicals | 1 | 2004 | 238 | 0.060 |
Why?
|
Dementia | 1 | 1998 | 2649 | 0.060 |
Why?
|
Tibia | 4 | 2013 | 1065 | 0.060 |
Why?
|
Fluorescent Dyes | 4 | 1992 | 1913 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2696 | 0.060 |
Why?
|
Electrocardiography | 1 | 2017 | 6414 | 0.060 |
Why?
|
Haplotypes | 1 | 2010 | 2764 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2021 | 20509 | 0.060 |
Why?
|
Longevity | 1 | 2011 | 1050 | 0.060 |
Why?
|
Transcranial Magnetic Stimulation | 2 | 2016 | 1469 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4573 | 0.050 |
Why?
|
Ticks | 1 | 2003 | 70 | 0.050 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 491 | 0.050 |
Why?
|
Rats, Inbred Strains | 4 | 1992 | 2094 | 0.050 |
Why?
|
Electric Stimulation | 1 | 2008 | 1735 | 0.050 |
Why?
|
Shock, Septic | 1 | 2009 | 761 | 0.050 |
Why?
|
Beverages | 1 | 2008 | 820 | 0.050 |
Why?
|
Spinal Muscular Atrophies of Childhood | 1 | 2004 | 114 | 0.050 |
Why?
|
Physical Therapy Modalities | 1 | 2006 | 536 | 0.050 |
Why?
|
Kidney Transplantation | 3 | 2016 | 4215 | 0.050 |
Why?
|
Gliosis | 1 | 2023 | 244 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2020 | 10181 | 0.050 |
Why?
|
Synucleins | 1 | 2002 | 107 | 0.050 |
Why?
|
Time Factors | 4 | 2017 | 40165 | 0.050 |
Why?
|
Electron Transport | 1 | 2003 | 206 | 0.050 |
Why?
|
Genetic Loci | 1 | 2012 | 2618 | 0.050 |
Why?
|
Bites and Stings | 1 | 2003 | 93 | 0.050 |
Why?
|
HIV Infections | 3 | 2016 | 17165 | 0.050 |
Why?
|
Administration, Oral | 1 | 2010 | 4035 | 0.050 |
Why?
|
Gene Rearrangement | 1 | 2007 | 1122 | 0.050 |
Why?
|
Endemic Diseases | 1 | 2003 | 190 | 0.050 |
Why?
|
Treatment Outcome | 10 | 2022 | 65017 | 0.050 |
Why?
|
Phosphatidylserines | 1 | 2023 | 188 | 0.050 |
Why?
|
Caudate Nucleus | 1 | 2023 | 389 | 0.050 |
Why?
|
Northern Territory | 1 | 2021 | 5 | 0.050 |
Why?
|
Cloning, Molecular | 2 | 2004 | 4169 | 0.050 |
Why?
|
Graft Rejection | 2 | 2012 | 4426 | 0.050 |
Why?
|
Sweden | 1 | 2005 | 1381 | 0.050 |
Why?
|
Rats, Sprague-Dawley | 4 | 1994 | 8158 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2488 | 0.050 |
Why?
|
Basal Ganglia Diseases | 1 | 2002 | 144 | 0.050 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2002 | 91 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2019 | 5397 | 0.050 |
Why?
|
Gene Deletion | 1 | 2009 | 2668 | 0.050 |
Why?
|
Streptococcal Infections | 1 | 2006 | 617 | 0.050 |
Why?
|
Low Back Pain | 1 | 2009 | 979 | 0.050 |
Why?
|
Environmental Pollutants | 1 | 2010 | 1266 | 0.050 |
Why?
|
Organizations | 1 | 2022 | 171 | 0.050 |
Why?
|
Autistic Disorder | 1 | 2010 | 1216 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8624 | 0.050 |
Why?
|
Sleep, REM | 1 | 2004 | 593 | 0.050 |
Why?
|
Axonal Transport | 2 | 1992 | 178 | 0.050 |
Why?
|
Prospective Studies | 3 | 2021 | 54303 | 0.050 |
Why?
|
Comorbidity | 2 | 2019 | 10551 | 0.050 |
Why?
|
Cell Survival | 4 | 2020 | 5797 | 0.050 |
Why?
|
Young Adult | 7 | 2020 | 58741 | 0.050 |
Why?
|
Glucose Clamp Technique | 1 | 2021 | 263 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2014 | 10827 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2012 | 3562 | 0.040 |
Why?
|
Motor Activity | 1 | 2010 | 2687 | 0.040 |
Why?
|
Chemokine CXCL13 | 1 | 2020 | 59 | 0.040 |
Why?
|
Anti-Bacterial Agents | 2 | 2009 | 7408 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2005 | 502 | 0.040 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2001 | 763 | 0.040 |
Why?
|
Nicotinamide Mononucleotide | 1 | 2019 | 17 | 0.040 |
Why?
|
Lewy Bodies | 1 | 2000 | 144 | 0.040 |
Why?
|
Adolescent | 9 | 2015 | 87810 | 0.040 |
Why?
|
Conserved Sequence | 1 | 2003 | 1167 | 0.040 |
Why?
|
Autopsy | 1 | 2023 | 1007 | 0.040 |
Why?
|
Child, Preschool | 6 | 2010 | 42063 | 0.040 |
Why?
|
Organic Cation Transport Proteins | 1 | 2019 | 58 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2020 | 2417 | 0.040 |
Why?
|
Phospholipids | 1 | 2023 | 789 | 0.040 |
Why?
|
Dopamine Plasma Membrane Transport Proteins | 1 | 2021 | 415 | 0.040 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2019 | 59 | 0.040 |
Why?
|
Optic Atrophies, Hereditary | 1 | 1999 | 27 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2004 | 2932 | 0.040 |
Why?
|
Gestational Age | 3 | 1992 | 3565 | 0.040 |
Why?
|
Family | 1 | 2010 | 3189 | 0.040 |
Why?
|
Metacarpophalangeal Joint | 1 | 2019 | 82 | 0.040 |
Why?
|
Mitochondrial Encephalomyopathies | 1 | 1999 | 40 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9631 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2001 | 388 | 0.040 |
Why?
|
Rheumatoid Factor | 1 | 2019 | 185 | 0.040 |
Why?
|
Monoamine Oxidase Inhibitors | 1 | 1999 | 155 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2015 | 3517 | 0.040 |
Why?
|
Myography | 1 | 2019 | 111 | 0.040 |
Why?
|
Synaptic Membranes | 1 | 1998 | 89 | 0.040 |
Why?
|
Blood | 1 | 2001 | 586 | 0.040 |
Why?
|
Neuropeptides | 1 | 2004 | 943 | 0.040 |
Why?
|
Lebanon | 1 | 2019 | 245 | 0.040 |
Why?
|
Immunoglobulin Class Switching | 1 | 2020 | 289 | 0.040 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2018 | 80 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 419 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 454 | 0.040 |
Why?
|
Kidney Failure, Chronic | 1 | 2010 | 2471 | 0.040 |
Why?
|
Polyradiculoneuropathy | 1 | 1997 | 65 | 0.040 |
Why?
|
Frontal Lobe | 2 | 1998 | 1420 | 0.040 |
Why?
|
Central Nervous System Diseases | 1 | 2002 | 521 | 0.040 |
Why?
|
Cell Size | 1 | 2019 | 624 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2010 | 3392 | 0.040 |
Why?
|
Apoptosis | 1 | 2013 | 9501 | 0.040 |
Why?
|
Kidney Calculi | 1 | 2021 | 468 | 0.040 |
Why?
|
Lyme Disease | 1 | 2003 | 630 | 0.040 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2018 | 159 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2021 | 12293 | 0.030 |
Why?
|
Cell Line, Transformed | 2 | 2009 | 869 | 0.030 |
Why?
|
Muscle Strength | 1 | 2021 | 619 | 0.030 |
Why?
|
Health Education | 1 | 2003 | 1049 | 0.030 |
Why?
|
Dopamine Agonists | 1 | 1999 | 352 | 0.030 |
Why?
|
Genetic Techniques | 1 | 1999 | 428 | 0.030 |
Why?
|
Environmental Exposure | 1 | 2010 | 4412 | 0.030 |
Why?
|
Sequence Analysis, DNA | 2 | 2004 | 4713 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 5 | 2019 | 36290 | 0.030 |
Why?
|
Electric Impedance | 1 | 2019 | 755 | 0.030 |
Why?
|
Fibroblasts | 2 | 2006 | 4090 | 0.030 |
Why?
|
Iron | 1 | 2023 | 1786 | 0.030 |
Why?
|
Microscopy, Electron | 1 | 1998 | 2558 | 0.030 |
Why?
|
Genetic Counseling | 1 | 1999 | 624 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 25942 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2016 | 6238 | 0.030 |
Why?
|
Color | 1 | 2016 | 298 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2003 | 1885 | 0.030 |
Why?
|
Pain | 1 | 2009 | 5066 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2009 | 14660 | 0.030 |
Why?
|
Genetic Testing | 2 | 2021 | 3531 | 0.030 |
Why?
|
Carrier Proteins | 2 | 2004 | 4938 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2020 | 1755 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2298 | 0.030 |
Why?
|
Blotting, Western | 1 | 2001 | 5039 | 0.030 |
Why?
|
Serbia | 1 | 2012 | 13 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2932 | 0.030 |
Why?
|
Lysosomes | 1 | 1998 | 920 | 0.030 |
Why?
|
Acetylglucosaminidase | 1 | 2012 | 67 | 0.030 |
Why?
|
Causality | 1 | 2019 | 1242 | 0.030 |
Why?
|
Hearing Loss, Sensorineural | 1 | 1999 | 781 | 0.030 |
Why?
|
Computational Biology | 1 | 2004 | 3505 | 0.030 |
Why?
|
Societies, Medical | 1 | 2024 | 3905 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2017 | 39261 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3336 | 0.030 |
Why?
|
Drug Implants | 1 | 1992 | 230 | 0.030 |
Why?
|
Speech Therapy | 1 | 2012 | 57 | 0.020 |
Why?
|
Probability | 1 | 2017 | 2475 | 0.020 |
Why?
|
Autonomic Nervous System | 1 | 2017 | 697 | 0.020 |
Why?
|
Polyvinyls | 1 | 1992 | 154 | 0.020 |
Why?
|
Chile | 1 | 2012 | 255 | 0.020 |
Why?
|
Macrophages | 2 | 2015 | 5745 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1999 | 1501 | 0.020 |
Why?
|
Abdomen, Acute | 1 | 2012 | 122 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2009 | 11903 | 0.020 |
Why?
|
Genome | 1 | 1999 | 1739 | 0.020 |
Why?
|
Untranslated Regions | 1 | 2011 | 29 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2008 | 10344 | 0.020 |
Why?
|
Refugees | 1 | 2019 | 598 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1004 | 0.020 |
Why?
|
Biopsy | 2 | 2004 | 6771 | 0.020 |
Why?
|
Rhodamines | 1 | 1991 | 179 | 0.020 |
Why?
|
Social Class | 1 | 2019 | 2005 | 0.020 |
Why?
|
Qualitative Research | 1 | 2021 | 2963 | 0.020 |
Why?
|
Chemokines | 1 | 2015 | 962 | 0.020 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2012 | 200 | 0.020 |
Why?
|
Osteoarthritis, Knee | 1 | 2021 | 1234 | 0.020 |
Why?
|
Neurites | 1 | 1992 | 390 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2007 | 20080 | 0.020 |
Why?
|
Random Allocation | 1 | 2015 | 2394 | 0.020 |
Why?
|
Cognition Disorders | 3 | 2012 | 3976 | 0.020 |
Why?
|
Phenotype | 3 | 2019 | 16546 | 0.020 |
Why?
|
Climate Change | 1 | 2016 | 488 | 0.020 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2010 | 143 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2015 | 820 | 0.020 |
Why?
|
Nasal Cavity | 1 | 1992 | 304 | 0.020 |
Why?
|
Light | 1 | 2016 | 1344 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 1997 | 2693 | 0.020 |
Why?
|
Logistic Models | 2 | 2017 | 13314 | 0.020 |
Why?
|
Canada | 1 | 2014 | 2128 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2010 | 17624 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2014 | 1180 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6029 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7269 | 0.020 |
Why?
|
Antigens, CD | 1 | 2019 | 4000 | 0.020 |
Why?
|
Patella | 1 | 2010 | 313 | 0.020 |
Why?
|
Spatial Behavior | 1 | 1989 | 88 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.020 |
Why?
|
Cerebral Cortex | 2 | 2005 | 5761 | 0.020 |
Why?
|
Infant | 3 | 2010 | 36060 | 0.020 |
Why?
|
Chemoprevention | 1 | 2010 | 326 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2009 | 296 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2019 | 18137 | 0.020 |
Why?
|
Antibodies | 2 | 2003 | 2421 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3839 | 0.020 |
Why?
|
Research | 1 | 2016 | 1974 | 0.020 |
Why?
|
Linear Models | 2 | 2012 | 5877 | 0.020 |
Why?
|
Schwann Cells | 1 | 1988 | 196 | 0.020 |
Why?
|
Regression Analysis | 1 | 2017 | 6360 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 2010 | 377 | 0.020 |
Why?
|
Embryo, Mammalian | 2 | 1991 | 1674 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18416 | 0.020 |
Why?
|
Caspase 3 | 1 | 2009 | 731 | 0.020 |
Why?
|
Leadership | 1 | 2016 | 1371 | 0.020 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2010 | 662 | 0.020 |
Why?
|
United States | 4 | 2019 | 72461 | 0.020 |
Why?
|
Transplantation, Homologous | 2 | 2010 | 4810 | 0.020 |
Why?
|
CREB-Binding Protein | 1 | 2006 | 148 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6597 | 0.020 |
Why?
|
Catalase | 1 | 2006 | 216 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 6015 | 0.020 |
Why?
|
Brain Mapping | 2 | 1992 | 6568 | 0.020 |
Why?
|
Radiation | 1 | 2005 | 48 | 0.020 |
Why?
|
Oxidants | 1 | 2006 | 169 | 0.020 |
Why?
|
Seizures | 1 | 1999 | 2917 | 0.020 |
Why?
|
Nitro Compounds | 1 | 2005 | 74 | 0.020 |
Why?
|
Species Specificity | 1 | 2010 | 2418 | 0.020 |
Why?
|
Visual Pathways | 1 | 1990 | 534 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2008 | 549 | 0.020 |
Why?
|
Amyloid beta-Peptides | 1 | 2019 | 3832 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 2006 | 256 | 0.020 |
Why?
|
Motor Skills Disorders | 1 | 2005 | 89 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2022 | 9185 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2005 | 295 | 0.020 |
Why?
|
Genome, Archaeal | 1 | 2004 | 20 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2013 | 2197 | 0.020 |
Why?
|
Propionates | 1 | 2005 | 182 | 0.020 |
Why?
|
Septum Pellucidum | 1 | 1985 | 54 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6498 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2010 | 2569 | 0.010 |
Why?
|
Peroxynitrous Acid | 1 | 2004 | 42 | 0.010 |
Why?
|
Hippocampus | 2 | 1989 | 3738 | 0.010 |
Why?
|
Environmental Monitoring | 1 | 2010 | 1441 | 0.010 |
Why?
|
Response Elements | 1 | 2005 | 308 | 0.010 |
Why?
|
Databases, Factual | 1 | 2019 | 8035 | 0.010 |
Why?
|
Superoxide Dismutase | 1 | 2006 | 594 | 0.010 |
Why?
|
DEET | 1 | 2003 | 10 | 0.010 |
Why?
|
Permethrin | 1 | 2003 | 15 | 0.010 |
Why?
|
Insect Repellents | 1 | 2003 | 17 | 0.010 |
Why?
|
Software | 1 | 2017 | 4419 | 0.010 |
Why?
|
Pamphlets | 1 | 2003 | 71 | 0.010 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 318 | 0.010 |
Why?
|
Medication Adherence | 1 | 2015 | 2165 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2006 | 732 | 0.010 |
Why?
|
Cell Membrane | 1 | 1992 | 3682 | 0.010 |
Why?
|
Functional Laterality | 1 | 1990 | 2253 | 0.010 |
Why?
|
Maryland | 1 | 2003 | 275 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2020 | 11481 | 0.010 |
Why?
|
Calreticulin | 1 | 2003 | 115 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3539 | 0.010 |
Why?
|
Pseudogenes | 1 | 2002 | 103 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 2002 | 190 | 0.010 |
Why?
|
Physical Endurance | 1 | 2004 | 363 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2005 | 1456 | 0.010 |
Why?
|
Cell Line, Tumor | 2 | 2009 | 16939 | 0.010 |
Why?
|
Introns | 1 | 2004 | 978 | 0.010 |
Why?
|
Artifacts | 1 | 2010 | 1898 | 0.010 |
Why?
|
Vitamins | 1 | 2009 | 1634 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10547 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2009 | 1504 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2004 | 756 | 0.010 |
Why?
|
Neural Pathways | 1 | 1991 | 3040 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 1999 | 5889 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6218 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6544 | 0.010 |
Why?
|
Cadaver | 1 | 2004 | 1345 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2005 | 1972 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18957 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2004 | 1832 | 0.010 |
Why?
|
Muscles | 1 | 2004 | 1581 | 0.010 |
Why?
|
Memory | 1 | 1989 | 2179 | 0.010 |
Why?
|
Nerve Regeneration | 1 | 1985 | 791 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8555 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13451 | 0.010 |
Why?
|
Mitochondrial Proteins | 1 | 2004 | 979 | 0.010 |
Why?
|
Sports | 1 | 2004 | 700 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4166 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 8803 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5781 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12159 | 0.010 |
Why?
|
Exercise Test | 1 | 2004 | 2128 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5785 | 0.010 |
Why?
|
Survival Rate | 1 | 2009 | 12808 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2016 | 80372 | 0.010 |
Why?
|
Phosphorylation | 1 | 2005 | 8313 | 0.010 |
Why?
|
Glioblastoma | 1 | 2009 | 3484 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21392 | 0.010 |
Why?
|
Stem Cells | 1 | 2006 | 3523 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6538 | 0.010 |
Why?
|
Heart | 1 | 2004 | 4393 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 15697 | 0.010 |
Why?
|
Pregnancy | 1 | 1991 | 29749 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2002 | 7021 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2003 | 3986 | 0.000 |
Why?
|
Liver | 1 | 2004 | 7509 | 0.000 |
Why?
|
Appetitive Behavior | 1 | 1985 | 39 | 0.000 |
Why?
|
Graft vs Host Disease | 1 | 1997 | 3025 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2004 | 26181 | 0.000 |
Why?
|
Orientation | 1 | 1985 | 321 | 0.000 |
Why?
|
Discrimination Learning | 1 | 1985 | 278 | 0.000 |
Why?
|
Theta Rhythm | 1 | 1985 | 217 | 0.000 |
Why?
|
Epitopes | 1 | 1988 | 2503 | 0.000 |
Why?
|
Cell Communication | 1 | 1988 | 1653 | 0.000 |
Why?
|
Action Potentials | 1 | 1989 | 1816 | 0.000 |
Why?
|
Mental Recall | 1 | 1985 | 1206 | 0.000 |
Why?
|